Technologies
Innovative technical and a variety of pipelines
“One-stop” gene and cell platform, covering all core technologies for CAR-T cell production
Technical Platforms
Imunopharm owns independent technical platforms for gene and cell therapy, including CAR-T screening system, large-scale plasmid preparation system, large-scale lentiviral vector preparation system, primary immune cells culture system and etc.
Gene vector scaling platform
Lentivirus serum-free and suspension culture system
High-efficacy gene vector purification process
Pilot-scale and large-scale production system
T Cell research and scaling platform
GMP-grade T cell scaling platform
Serum-free culture condition
InnovaCART: CAR design and screening platform
DuraCART: Long-term T cell persistence
HPCART: Fast CAR-T preparation
UCART: Batch in stock CAR-T R&D Platform
Gene and cell drug analysis platform
Complete plasmid/virus/cell analysis method
GMP quality control system
